Prevention of Venous Thrombosis After Permanent Transvenous Leads Implantation
Status:
Completed
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
The aim of this study was to compare the safety and efficacy of warfarin versus placebo,
administered for 6 months, in the prevention of thromboembolic complications after
transvenous cardiac devices implantation in high-risk patients.
Phase:
N/A
Details
Lead Sponsor:
University of Sao Paulo
Collaborators:
Conselho Nacional de Desenvolvimento Científico e Tecnológico Fundação de Amparo à Pesquisa do Estado de São Paulo